Futura Medical's Patent Win Extends US Market Protection for Eroxon and Pipeline Women's Health Product to 2040
UK-based Futura Medical secures a key US patent allowance, safeguarding its erectile dysfunction gel Eroxon and an investigational women's sexual health treatment until 2040, while triggering a $2.5 million milestone payment from partner Haleon.